EricStephenSchaferMD

Pediatric Hematology & Oncology • Houston, TX

Assistant Professor of Pediatrics, Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, TX

Join to view full profile

Dr. Schafer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Schafer's full profile

Already have an account?

Office
6701 Fannin St
Houston, TX 77030
Phone+1 832-824-1000

Fax+1 410-955-0028

Education & Training

Baylor College of MedicineFellowship, Clinical Pharmacology, 2012 - 2015
Johns Hopkins Bloomberg School of Public HealthMHS, Clinical Investigation, 2011 - 2012
Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2006 - 2009
Children's Hospital of PhiladelphiaResidency, Pediatrics, 2003 - 2006
Baylor College of MedicineClass of 2003

Certifications & Licensure

TX State Medical License 2012 - 2026
MD State Medical License 2006 - 2013
PA State Medical License 2003 - 2006
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Phase I Study of LDK378 in Pediatric, Malignancies With a Genetic Alteration in Anaplastic Lymphoma Kinase (ALK) Start of enrollment: 2013 Aug 28
Completed
Phase 1
Individualized High Dose Methotrexate to Treat Cancer in Children Who Have a Significant Risk for Side Effects to Methotrexate Start of enrollment: 2014 Jan 01
Completed
Not Applicable
Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies Start of enrollment: 2014 May 16
Completed
Phase 1, Phase 2
Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia Start of enrollment: 2020 Apr 06
Active, not recruiting
Phase 1, Phase 2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

50 citations
Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma.
David T Teachey, Meenakshi Devidas, Brent L Wood, Zhiguo Chen, Robert J Hayashi
Journal of Clinical Oncology. 2022-07-01
43 citations
Phase 1/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory/recurrent solid tumors including Ewing sarcoma: A Children'...
Eric S. Schafer, Rachel E. Rau, Stacey L. Berg, Xiaowei Liu, Charles G. Minard
Pediatric Blood & Cancer. 2020-02-01
10 citations
Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Child...
Sarah K Tasian, Lewis B Silverman, James A Whitlock, Richard Sposto, Joseph P Loftus
Haematologica. 2022-10-01

Abstracts/Posters

Phase 1 Study of Decitabine and Vorinostat Followed By Fludarabine, Cytarabine and G-CSF (FLAG) in Children, Adolescents and Young Adults with Relapsed/Refractory AML:...
Eric Schafer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019